Cameron Pye

Money Moves

Will lead the Santa Cruz peptide discovery team after closing

Every medicine argenx sells today reaches patients by infusion or injection. On Nov. 9, 2026, the Dutch immunology company agreed to pay $550 million in cash for a Santa Cruz company whose chemistry is built to make pills instead.

Updated Yesterday